Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Balchem (BCPC) EBT (2016 - 2026)

Balchem (BCPC) has disclosed EBT for 17 consecutive years, with $52.5 million as the latest value for Q1 2026.

  • For Q1 2026, EBT rose 9.56% year-over-year to $52.5 million; the TTM value through Mar 2026 reached $203.6 million, up 14.68%, while the annual FY2025 figure was $199.0 million, 19.57% up from the prior year.
  • EBT hit $52.5 million in Q1 2026 for Balchem, up from $50.0 million in the prior quarter.
  • Across five years, EBT topped out at $52.5 million in Q1 2026 and bottomed at $25.8 million in Q4 2022.
  • Average EBT over 5 years is $40.5 million, with a median of $39.3 million recorded in 2022.
  • Year-over-year, EBT dropped 22.62% in 2023 and then surged 33.72% in 2024.
  • Balchem's EBT stood at $25.8 million in 2022, then grew by 29.06% to $33.3 million in 2023, then surged by 33.72% to $44.5 million in 2024, then increased by 12.48% to $50.0 million in 2025, then grew by 4.97% to $52.5 million in 2026.
  • According to Business Quant data, EBT over the past three periods came in at $52.5 million, $50.0 million, and $52.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.